December 2020 FDA Recall Drug by Kvk-tech, Inc.
D-0224-2021 - Failed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892A

This Class III drug recall was voluntarily initiated by Kvk-tech, Inc. on December 18, 2020 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications; out of specification results obtained for n-oxide impurity during the 12-month long term stability testing for batch# 15892a. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0224-2021

Reason for Recall
Failed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892A
Initiated
12-18-2020
Reported
01-20-2021
Quantity
528 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Benzhydrocodone and Acetaminophen Tablets, CII, 6.12mg/ 325mg, 100 Tablets, Rx Only, Manufactured for: KVK-Tech, Inc., Newtown, PA 18940 USA, NDC 10702-344-01

Batch or Lot Expiration Information

Batch# 15892A, Exp, 2021-FEB